Form 8-K - Current report:
SEC Accession No. 0001558370-25-000639
Filing Date
2025-02-05
Accepted
2025-02-05 06:30:31
Documents
16
Period of Report
2025-01-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tech-20250130x8k.htm   iXBRL 8-K 44075
2 EX-99.1 tech-20250130xex99d1.htm EX-99.1 634363
3 EX-99.2 tech-20250130xex99d2.htm EX-99.2 21087
4 EX-99.3 tech-20250130xex99d3.htm EX-99.3 9182
  Complete submission text file 0001558370-25-000639.txt   873383

Data Files

Seq Description Document Type Size
5 EX-101.SCH tech-20250130.xsd EX-101.SCH 3394
6 EX-101.LAB tech-20250130_lab.xml EX-101.LAB 15263
7 EX-101.PRE tech-20250130_pre.xml EX-101.PRE 10902
18 EXTRACTED XBRL INSTANCE DOCUMENT tech-20250130x8k_htm.xml XML 4649
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 25590768
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)